M&A Deal Summary |
|
---|---|
Date | 2015-09-09 |
Target | Alligent Biopharm Consulting |
Sector | Business Services |
Buyer(s) | Envision Pharma |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Envision Pharma is a global technology and scientific communication company serving the pharmaceutical, biotechnology, and medical device companies. Envision has grown steadily under consistent leadership across its three core business areas that include (i) Scientific Solutions – strategic publication planning and related data dissemination services; (ii) Technology Solutions – design, development, implementation, and support of innovative and strategic management software for life sciences clients including publication planning and management (DatavisionTM), clearance approval (dvClear™), and activity request management (Visiontracker) and (iii) Professional Consulting Solutions policy, process, compliance and guideline consultancy to life-science companies. Envision Pharma was founded in 2001 and is based in Horsham, United Kingdom.
DEAL STATS | # |
---|---|
Overall | 2 of 5 |
Sector (Business Services) | 2 of 2 |
Type (Add-on Acquisition) | 2 of 5 |
State (New Jersey) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-01-17 |
ProScribe Pty
Noosaville, Australia ProScribe Pty Ltd. is a medical writing company. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-04-08 |
90TEN Group
London, United Kingdom 90TEN Group Ltd. is an independent healthcare communications consultancy that specialises in using proven behavioural change tools to maximise brand and health outcomes. The company delivers highly creative, award-winning global and international public relations, medical education and patient engagement programmes for pharmaceutical and healthcare clients. 90TEN Group was formed in 2001 and is based in London. |
Buy | - |